Theodore R. Schroeder - 30 Sep 2021 Form 4 Insider Report for Nabriva Therapeutics plc

Role
Chief Executive Officer, Director
Signature
/s/ Christopher Naftzger, by power of attorney
Issuer symbol
N/A
Transactions as of
30 Sep 2021
Net transactions value
-$127
Form type
4
Filing time
04 Oct 2021, 16:14:40 UTC
Previous filing
15 Sep 2021
Next filing
08 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Tax liability $127 -107 -0.05% $1.19 226,768 30 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.